Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$163.89
Market cap
$18.29B
P/E Ratio
21.79
Dividend/share
$2.96
EPS
$7.52
Enterprise value
$24.5B
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals
Highlights
Quest Diagnostics's quick ratio has increased by 29% QoQ and by 16% YoY
DGX's EPS is up by 11% year-on-year
DGX's price to earnings (P/E) is 47% higher than its 5-year quarterly average of 14.8 and 17% higher than its last 4 quarters average of 18.7
Quest Diagnostics's debt has increased by 42% YoY and by 37% QoQ
Key stats
What are the main financial stats of DGX
Market
Valuations
Earnings
Shares outstanding
111.62M
Market cap
$18.29B
Enterprise value
$24.5B
Price to earnings (P/E)
21.79
Price to book (P/B)
2.68
Price to sales (P/S)
1.92
EV/EBIT
19.41
EV/EBITDA
14.17
EV/Sales
2.57
Revenue
$9.54B
EBIT
$1.26B
EBITDA
$1.73B
Free cash flow
$1.02B
Per share
Balance sheet
Liquidity
EPS
$7.52
Free cash flow per share
$9.13
Book value per share
$61.17
Revenue per share
$85.17
TBVPS
$51.55
Total assets
$16.1B
Total liabilities
$9.25B
Debt
$6.97B
Equity
$6.81B
Working capital
$531M
Debt to equity
1.02
Current ratio
1.25
Quick ratio
1.02
Net debt/EBITDA
3.59
Margins
Efficiency
Dividend
EBITDA margin
18.1%
Gross margin
32.7%
Net margin
8.8%
Operating margin
13.1%
Return on assets
5.8%
Return on equity
12.9%
Return on invested capital
15.3%
Return on capital employed
9%
Return on sales
13.2%
Dividend yield
1.81%
DPS
$2.96
Payout ratio
39.4%
DGX stock price
How has the Quest Diagnostics stock price performed over time
Intraday
1.59%
1 week
4.5%
1 month
11.21%
1 year
22.01%
YTD
18.86%
QTD
5.57%
Financial performance
How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.54B
Gross profit
$3.12B
Operating income
$1.25B
Net income
$841M
Gross margin
32.7%
Net margin
8.8%
DGX's operating income is up by 11% year-on-year
The net income has grown by 10% YoY
Quest Diagnostics's net margin has increased by 7% YoY but it has decreased by 2.2% QoQ
The company's operating margin rose by 7% YoY but it fell by 3% QoQ
Growth
What is Quest Diagnostics's growth rate over time
Valuation
What is Quest Diagnostics stock price valuation
P/E
21.79
P/B
2.68
P/S
1.92
EV/EBIT
19.41
EV/EBITDA
14.17
EV/Sales
2.57
DGX's price to earnings (P/E) is 47% higher than its 5-year quarterly average of 14.8 and 17% higher than its last 4 quarters average of 18.7
DGX's EPS is up by 11% year-on-year
The stock's price to book (P/B) is 12% more than its last 4 quarters average of 2.4 and 7% more than its 5-year quarterly average of 2.5
Quest Diagnostics's equity has increased by 6% YoY and by 2.9% from the previous quarter
The stock's price to sales (P/S) is 13% more than its 5-year quarterly average of 1.7 and 13% more than its last 4 quarters average of 1.7
The revenue has grown by 2.6% YoY and by 2.1% from the previous quarter
Efficiency
How efficient is Quest Diagnostics business performance
DGX's return on sales is up by 10% year-on-year
Quest Diagnostics's return on invested capital has decreased by 6% QoQ but it has increased by 3.4% YoY
DGX's return on assets is down by 4.9% since the previous quarter
DGX's ROE is up by 4% year-on-year
Dividends
What is DGX's dividend history
DPS
$2.96
Dividend yield
1.81%
Payout ratio
39.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Quest Diagnostics financials performed over time
The total assets is 74% greater than the total liabilities
The company's total liabilities rose by 32% YoY and by 28% QoQ
Quest Diagnostics's quick ratio has increased by 29% QoQ and by 16% YoY
Quest Diagnostics's debt is 2.4% higher than its equity
Quest Diagnostics's debt has increased by 42% YoY and by 37% QoQ
The company's debt to equity rose by 34% YoY and by 32% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.